---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-309426"
form_type: "8-K"
ticker: "HCA"
cik: "0000860730"
company_name: "HCA Healthcare, Inc."
filed_at: "2021-10-27T23:59:59+00:00"
generated_at: "2026-06-28T17:44:39.470835+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# HCA Healthcare EVP & Chief Clinical Officer appointment; Dr. Perlin to depart March 2022

## Summary
- Dr. Jonathan B. Perlin will depart as President-Clinical Ops and CMO to become CEO of The Joint Commission, effective March 1, 2022.
- Dr. Perlin remains in current role through Dec 31, 2021; transition period from Jan 1 to Feb 28, 2022.
- Effective Jan 1, 2022, Dr. Michael S. Cuffe named Executive Vice President and Chief Clinical Officer.
- Board approved the changes at October 21, 2021 meeting; orderly succession for a key clinical leadership role.

## SEC filing metadata
- accession: 0001193125-21-309426
- form_type: 8-K
- ticker: HCA
- cik: 0000860730
- company_name: HCA Healthcare, Inc.
- filed_at: 2021-10-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/860730/000119312521309426/0001193125-21-309426-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/860730/000119312521309426/d222794d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-309426
- JSON: https://secwatch.observer/filing/0001193125-21-309426.json
- Plain text: https://secwatch.observer/filing/0001193125-21-309426.txt

## Key facts
- Executive change
  Jonathan B. Perlin departed as President - Clinical Operations Group and Chief Medical Officer at HCA Healthcare, Inc..
  - Action: notified
  - Role: President - Clinical Operations Group and Chief Medical Officer
  source text: Dr. Jonathan B. Perlin, President - Clinical Operations Group and Chief Medical Officer, notified HCA Healthcare, Inc. (the “Company”) on September 16, 2021 that he had accepted the role of president and CEO of The Joint Commission and will assume his new role on March 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/860730/000119312521309426/0001193125-21-309426-index.htm
- Executive change
  Michael S. Cuffe was appointed as Executive Vice President and Chief Clinical Officer at HCA Healthcare, Inc..
  - Action: appointed
  - Role: Executive Vice President and Chief Clinical Officer
  source text: effective January 1, 2022, Dr. Michael S. Cuffe will become Executive Vice President and Chief Clinical Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/860730/000119312521309426/0001193125-21-309426-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.